Circulating Thrombomodulin as a Clue of Endothelial Damage in Behçet’s Disease

• References

• 1 Takano S, Kimura S, Ohdama S, Aoki N. Plasma thrombomodulin in health and diseases. Blood 1990; 76: 2024-2029
• 2 Esmon NL. Thrombomodulin. Sem Thromb Hemost 1987; 13: 454-463
• 3 Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest 1985; 76: 2178
• 4 Chamberlain MA, Hampton KK, Menon D, Davies JA. Coagulation and fibrinolytic activity in Beliefs disease. In: Behçet’s Disease Basic and Clinical Aspects O’Duffy JD, Kokmen E. eds. Rochester: Mayo Clinic; 1991: 541-544
• 5 Amiral J, Adam M, Mimilla F, Larrivaz I, Chambrette B, Boffa MC. Design and validation of a new immunoassay for soluble forms of thrombomodulin and studies on plasma. Hybridoma 1994; 13: 205-213
• 6 Wada H, Ohiwa M, Kaneko T, Tamaki S, Tanigawa M, Shirakawa S, Koyama M, Hayashi T, Suzuki K. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Am J Hematol 1992; 39: 20-24
• 7 Oida K, Takai H, Maeda H, Takahashi S, Tamai T, Nakai T, Miyabo S, Ishii H. Plasma thrombomodulin concentrations in diabetes mellitus. Diabetes Res Clin Pract 1990; 10: 193-196
• 8 Takaya M, Ichikawa Y, Kawada T, Shimuzu H, Uchiyama M, Moriuchi J, Watanabe K, Arimori S. Serum thrombomodulin and anticardiolipin antibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1991; 9: 495-499
• 9 Tomura S, Nakamura X, Deguchi F, Chida Y, Ohno Y, Kodama S, Hayashi T, Suzuki K, Marumo F. Plasma Von Willebrand factor and thrombomodulin as markers of vascular disorders in patients undergoing regular hemodialysis therapy. Thromb Res 1990; 58: 413-419
• 10 Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991; 65: 618-623
• 11 Takahashi H, Tatewaki W, Wada K, Niwano H, Hanano M, Tsubouchi J, Nagai T, Shibata A. DDAVP does not induce the release of thrombomodulin from endothelial cells. Thromb Haemost 1991; 65: 451
• 12 Takahashi H, Ito S, Hanano M, Wada K, Niwano H, Seki Y, Shibata A. Circulating thrombomodulin as a novel endothelial cell marker: comparison of its behaviour with von Willebrand factor and tissue-type plasminogen activator. Am J Hematol 1992; 41: 32-39
• 13 Tribout B, Huong DULT, Gozin D, Karmochkine M, Wechsler B, Godeau P, Boffa MC. Low levels of circulating thrombomodulin in patients with Behcet’s disease. Sixth International Conference on Behget’s Disease, held in Paris, France, 30th June-1st July 1993.